Abstract
There has been increasing concern recently in ensuring that public funding for science and innovation creates truly public benefits. This has emerged at a time of an uneasy feeling emerging in society that it is private corporations and patent holders that reap the rewards, particularly in new drugs which may be generally unaffordable despite being ‘discovered’ by public funding.
Original language | English |
---|---|
Publisher | Elephant in the Lab |
Publication status | Published - 13 Sep 2018 |